Authors:
Nemunaitis, J
Khuri, F
Ganly, I
Arseneau, J
Posner, M
Vokes, E
Kuhn, J
McCarty, T
Landers, S
Blackburn, A
Romel, L
Randlev, B
Kaye, S
Kirn, D
Citation: J. Nemunaitis et al., Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer, J CL ONCOL, 19(2), 2001, pp. 289-298
Authors:
Nemunaitis, J
Ganly, I
Khuri, F
Arseneau, J
Kuhn, J
McCarty, T
Landers, S
Maples, P
Romel, L
Randlev, B
Reid, T
Kaye, S
Kirn, D
Citation: J. Nemunaitis et al., Selective replication and oncolysis in p53 mutant tumors with ONYX-015, anE1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: A Phase II trial, CANCER RES, 60(22), 2000, pp. 6359-6366
Authors:
Flood, W
Lee, DJ
Trotti, A
Spencer, S
Murphy, B
Khuri, F
DeConti, R
Wheeler, R
Forastiere, AA
Citation: W. Flood et al., Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: Preliminary results of two pilot trials using paclitaxel and cisplatin, SEM RAD ONC, 9(2), 1999, pp. 64-69